Article Details

Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for ...

Retrieved on: 2021-01-11 11:03:45

Tags for this article:

Click the tags to see associated articles and topics

Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for .... View article details on hiswai:

Excerpt

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing its proprietary RNA ...

Article found on: www.manchestertimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up